Summary:
The purpose of this study is to learn about the effects effectiveness of RPC1063 in RMS. This trial may take up to 3 months.
Qualified Participants Must:
Be between 18 and 55 years of age (Adult)
Diagnosed with relapsing MS
Qualified Participants May Receive:
Study-related medical care and investigational drug at no cost and may be compensated for time and travel.